Ikeda M - Search Results

1

Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials.

Llovet JM, Singal AG, Villanueva A, Finn RS, Kudo M, Galle PR, Ikeda M, Callies S, McGrath LM, Wang C, Abada P, Widau RC, Gonzalez-Gugel E, Zhu AX. Llovet JM, et al. Among authors: ikeda m. Clin Cancer Res. 2022 Jun 1;28(11):2297-2305. doi: 10.1158/1078-0432.CCR-21-4000. Clin Cancer Res. 2022. PMID: 35247922 Free PMC article.

2

Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.

Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Okusaka T, et al. Among authors: ikeda m. Cancer. 2002 Nov 1;95(9):1931-7. doi: 10.1002/cncr.10892. Cancer. 2002. PMID: 12404287 Free article.

3

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.

Kuriyama H, Okada S, Okusaka T, Ueno H, Ikeda M. Kuriyama H, et al. Among authors: ikeda m. J Gastroenterol Hepatol. 2002 Nov;17(11):1205-10. doi: 10.1046/j.1440-1746.2002.02807.x. J Gastroenterol Hepatol. 2002. PMID: 12453281

4

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Ikeda M, Okada S, Yamamoto S, Sato T, Ueno H, Okusaka T, Kuriyama H, Takayasu K, Furukawa H, Iwata R. Ikeda M, et al. Jpn J Clin Oncol. 2002 Nov;32(11):455-60. doi: 10.1093/jjco/hyf097. Jpn J Clin Oncol. 2002. PMID: 12499417

5

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C. Ikeda M, et al. Cancer. 2005 Feb 15;103(4):756-62. doi: 10.1002/cncr.20841. Cancer. 2005. PMID: 15637692 Free article. Clinical Trial.

6

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.

Yonemori K, Ueno H, Okusaka T, Yamamoto N, Ikeda M, Saijo N, Yoshida T, Ishii H, Furuse J, Sugiyama E, Kim SR, Kikura-Hanajiri R, Hasegawa R, Saito Y, Ozawa S, Kaniwa N, Sawada J. Yonemori K, et al. Among authors: ikeda m. Clin Cancer Res. 2005 Apr 1;11(7):2620-4. doi: 10.1158/1078-0432.CCR-04-1497. Clin Cancer Res. 2005. PMID: 15814642 Clinical Trial.

7

Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Morizane C, Kojima Y, Iwasa S, Hagihara A. Ikeda M, et al. Jpn J Clin Oncol. 2008 Oct;38(10):675-82. doi: 10.1093/jjco/hyn087. Epub 2008 Aug 20. Jpn J Clin Oncol. 2008. PMID: 18716041

8

Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.

Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Hagihara A, Iwasa S, Kojima Y. Tanaka T, et al. Among authors: ikeda m. Jpn J Clin Oncol. 2008 Nov;38(11):755-61. doi: 10.1093/jjco/hyn098. Epub 2008 Oct 8. Jpn J Clin Oncol. 2008. PMID: 18845521

9

[Chemotherapy].

Ikeda M, Nakachi K, Mitsunaga S, Ueno H, Morizane C, Kondo S, Okusaka T. Ikeda M, et al. Gan To Kagaku Ryoho. 2010 Mar;37(3):408-12. Gan To Kagaku Ryoho. 2010. PMID: 20332676 Review. Japanese.

10

Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma.

Okusaka T, Ueno H, Ikeda M, Takezako Y, Morizane C. Okusaka T, et al. Among authors: ikeda m. Cancer Sci. 2012 Aug;103(8):1524-30. doi: 10.1111/j.1349-7006.2012.02334.x. Epub 2012 Jun 18. Cancer Sci. 2012. PMID: 22587457 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,513 results

Search Page